Company / SG&A per Share
Avanos Medical, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$6.87
FY2025
5-year range
$5.95 / $7.20
FY2021-FY2025
Trend
-0.5%
vs FY2024
Sector context
#56 of 150
Health Care
What the data says
At $6.87, Avanos Medical, Inc.'s sg&a per share ranks #95 of 150 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $5.95 in FY2021 to $8.41 in FY2019.
Based on SEC 10-K filings.
6.87 in FY2025 with a 5-year CAGR of -0.3%.
Improved from $7.20 to $6.87 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +0.5%
- 5-Year CAGR
- -0.3%
- 10-Year CAGR
- -
Sector benchmark
#95 of 150 in Health CareTop 63% of 150This company $6.87 Sector average $11878.17
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 0.5% year-over-year.
- Ranks #56 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.87 | -0.5% |
| FY2024 | $6.90 | -4.2% |
| FY2023 | $7.20 | +6.3% |
| FY2022 | $6.77 | +13.8% |
| FY2021 | $5.95 | -14.5% |
| FY2020 | $6.97 | -17.2% |
| FY2019 | $8.41 | +15.9% |
| FY2018 | $7.25 | +5.3% |
| FY2017 | $6.89 | -7.2% |
| FY2016 | $7.43 | -1.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026